Gabriela Rondon MD

Dr. Gabriela Rondón is an Associate Professor in the Department of Stem Cell Transplantation and Cellular Therapy at the M. D. Anderson Cancer Center in Houston, Texas. She completed her Post Doctoral fellowship training here at the University of Texas M. D. Anderson and began her tenure in 1995. She has made important clinical observations resulting in the description of a “graft versus leukemia effect in CLL” as well as defining the role of different strategies for the treatment of graft failure that has led to our current “standards of practice” within the department.

Dr. Rondón has been a close collaborator of Dr. Martin Korbling in his research related to the potential role of stem cell plasticity. In recent years she has instituted a prospective toxicity grading system by the protocol research staff for all SCTCT clinical trials, which has markedly improved the objectivity and responsibility of toxicity grading. As the Director of Protocol Research and Data Management. She has been actively involved in implementing strategies to assure successful protocol development and execution.

She has also lead one of our most important obligations related to our data management activities with the Center for International Blood and Marrow Transplant Research (CIBMTR) and is an active member of hematology and oncology professional societies including American Association for Cancer Research, American Society of Hematology, and American Society for Blood and Marrow Transplantation.